The effect of vericiguat on sudden cardiac death: insights from the VICTOR trial
Francesco Fioretti, Faı̈ez Zannad, Irina Barash, Stefano Corda et autres
Sudden cardiac death constitutes a significant risk in patients with heart failure and reduced ejection fraction (HFrEF). This risk is proportionally higher in those with less advanced disease and is not confined to periods of clinical instability. Previous studies have shown that …
us, fr, ch, ca, sg (code pays fourni par la source)